Marketing Guidelines

These Marketing Guidelines reflect CMS’ current interpretation of the marketing requirements and relate d provisions of the Medicare Advantage and Medicare Prescription
Drug Benefit rules (Chapter 42 of the Code of Federal Regulations, Parts 422 and 423). These guidelines were developed after careful evaluation by CMS of current industry marketing practices, recent advancements in communication technology, and how best to protect the interests of Medicare beneficiaries. The marketing guidance set forth in this document may be subject to change as communication technology and industry marketing practices continue to evolve, and as CMS gains more experience administering the Medicare Prescription Drug Benefit and Medicare Advantage programs.